Healthcare provider profile · identity verified

Wayne Robert Miller, MD

Allopathic & Osteopathic Physicians|Internal Medicine · SHAMOKIN, PA · NPI 1629039995

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Wayne Robert Miller, MD received $131.17 in general payments during 2025 across 2 reported records.

Lilly USA, LLC accounted for 86.6% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 347 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$131.17

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$113.56	86.6%	1	2025
Dexcom, Inc.	Unresolved — no canonical attribution shown	$17.61	13.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$131.17	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
KISUNLA Normalized: kisunla	Drug	Lilly USA, LLC	$113.56	1	2025
Source payment records 2025-10-29 · Lilly USA, LLC · $113.56 · Open Payments source
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$17.61	1	2025
Source payment records 2025-11-18 · Dexcom, Inc. · $17.61 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	347	62
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	16	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1332	324
Omeprazole	Omeprazole	1237	306
Amlodipine Besylate	Amlodipine Besylate	1006	232
Levothyroxine Sodium	Levothyroxine Sodium	818	161
Lisinopril	Lisinopril	751	183
Metoprolol Succinate	Metoprolol Succinate	705	174
Metformin Hcl	Metformin Hcl	559	125
Sertraline Hcl	Sertraline Hcl	558	106
Furosemide	Furosemide	497	120
Eliquis	Apixaban	474	62
Potassium Chloride	Potassium Chloride	442	112
Warfarin Sodium	Warfarin Sodium	427	42
Gabapentin	Gabapentin	411	85
Donepezil Hcl	Donepezil Hcl	384	64
Jardiance	Empagliflozin	347	62
Prednisone	Prednisone	314	158
Tamsulosin Hcl	Tamsulosin Hcl	312	75
Oxycodone Hcl	Oxycodone Hcl	304	44
Lorazepam	Lorazepam	294	57
Clopidogrel	Clopidogrel Bisulfate	291	59
Metoprolol Tartrate	Metoprolol Tartrate	285	65
Rosuvastatin Calcium	Rosuvastatin Calcium	283	73
Pravastatin Sodium	Pravastatin Sodium	280	59
Quetiapine Fumarate	Quetiapine Fumarate	247	34
Atenolol	Atenolol	234	58
Pantoprazole Sodium	Pantoprazole Sodium	229	44
Glipizide	Glipizide	212	49
Tramadol Hcl	Tramadol Hcl	202	36
Trazodone Hcl	Trazodone Hcl	198	41
Famotidine	Famotidine	189	42
Simvastatin	Simvastatin	189	50
Alendronate Sodium	Alendronate Sodium	186	38
Clonazepam	Clonazepam	173	17
Allopurinol	Allopurinol	171	33
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	166	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	165	44
Albuterol Sulfate Hfa	Albuterol Sulfate	164	49
Losartan Potassium	Losartan Potassium	150	41
Alprazolam	Alprazolam	144	21
Mirtazapine	Mirtazapine	143	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	143	21
Carvedilol	Carvedilol	138	26
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	130	52
Fluoxetine Hcl	Fluoxetine Hcl	130	24
Triamcinolone Acetonide	Triamcinolone Acetonide	128	58
Hydrochlorothiazide	Hydrochlorothiazide	127	33
Doxazosin Mesylate	Doxazosin Mesylate	121	31
Montelukast Sodium	Montelukast Sodium	121	28
Duloxetine Hcl	Duloxetine Hcl	120	27
Memantine Hcl	Memantine Hcl	118	13
Valsartan	Valsartan	117	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	115	82
Levofloxacin	Levofloxacin	114	57
Divalproex Sodium	Divalproex Sodium	111	18
Ozempic	Semaglutide	111	21
Glipizide Er	Glipizide	107	32
Buspirone Hcl	Buspirone Hcl	104	18
Bupropion Xl	Bupropion Hcl	103	19
Fluticasone Propionate	Fluticasone Propionate	100	31
Venlafaxine Hcl Er	Venlafaxine Hcl	94	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	93	28
Oseltamivir Phosphate	Oseltamivir Phosphate	93	61
Pregabalin	Pregabalin	93	15
Carbidopa-Levodopa	Carbidopa/Levodopa	92	20
Amoxicillin	Amoxicillin	91	44
Citalopram Hbr	Citalopram Hydrobromide	91	17
Ezetimibe	Ezetimibe	89	22
Ciprofloxacin Hcl	Ciprofloxacin Hcl	88	55
Meloxicam	Meloxicam	86	23
Azithromycin	Azithromycin	84	74
Escitalopram Oxalate	Escitalopram Oxalate	84	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	83	20
Clindamycin Hcl	Clindamycin Hcl	81	44
Colestipol Hcl	Colestipol Hcl	81	16
Nortriptyline Hcl	Nortriptyline Hcl	80	14
Finasteride	Finasteride	79	20
Levetiracetam	Levetiracetam	79	14
Paroxetine Hcl	Paroxetine Hcl	76	17
Naproxen	Naproxen	75	25
Mupirocin	Mupirocin	74	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	19
Tolterodine Tartrate	Tolterodine Tartrate	65	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	16
Telmisartan	Telmisartan	61	17
Torsemide	Torsemide	61	12
Metformin Hcl Er	Metformin Hcl	57	14
Nitroglycerin	Nitroglycerin	57	37
Olanzapine	Olanzapine	57	suppressed
Rybelsus	Semaglutide	53	11
Lovastatin	Lovastatin	52	14
Celecoxib	Celecoxib	51	11
Fluconazole	Fluconazole	51	24
Lamotrigine	Lamotrigine	51	suppressed
Xarelto	Rivaroxaban	50	suppressed
Risperidone	Risperidone	49	suppressed
Morphine Sulfate Er	Morphine Sulfate	48	suppressed
Fentanyl	Fentanyl	47	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	47	11
Amiodarone Hcl	Amiodarone Hcl	45	11
Ibuprofen	Ibuprofen	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	20
Digoxin	Digoxin	41	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	16
Ketoconazole	Ketoconazole	41	14
Gentamicin Sulfate	Gentamicin Sulfate	39	27
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	38	38
Spironolactone	Spironolactone	38	13
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	37	suppressed
Metolazone	Metolazone	36	15
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	33	suppressed
Farxiga	Dapagliflozin Propanediol	32	suppressed
Jantoven	Warfarin Sodium	32	suppressed
Aripiprazole	Aripiprazole	31	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Diclofenac Potassium	Diclofenac Potassium	31	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	31	suppressed
Albuterol Sulfate	Albuterol Sulfate	30	16
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	23
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	11
Nifedipine Er	Nifedipine	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	28	suppressed
Baclofen	Baclofen	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Cephalexin	Cephalexin	27	17
Meclizine Hcl	Meclizine Hcl	27	17
Nystatin	Nystatin	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Benztropine Mesylate	Benztropine Mesylate	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	13
Doxepin Hcl	Doxepin Hcl	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Estradiol	Estradiol	24	suppressed
Nitroglycerin Patch	Nitroglycerin	24	suppressed
Xtampza Er	Oxycodone Myristate	24	suppressed
Morphine Sulfate	Morphine Sulfate	23	12
Sucralfate	Sucralfate	23	suppressed
Brilinta	Ticagrelor	22	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	22	suppressed
Latanoprost	Latanoprost	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	19
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Calcitriol	Calcitriol	21	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Rivastigmine	Rivastigmine	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Topiramate	Topiramate	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Anastrozole	Anastrozole	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Insulin Aspart	Insulin Aspart	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Clotrimazole	Clotrimazole	19	suppressed
Econazole Nitrate	Econazole Nitrate	19	suppressed
Gemtesa	Vibegron	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Carbamazepine Er	Carbamazepine	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Mesalamine	Mesalamine	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	17	suppressed
Budesonide	Budesonide	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Movantik	Naloxegol Oxalate	16	suppressed
Probenecid	Probenecid	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Imipramine Hcl	Imipramine Hcl	14	suppressed
Lidocaine Hcl	Lidocaine Hcl	14	suppressed
Methimazole	Methimazole	14	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	14	14
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Victoza 3-Pak	Liraglutide	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Budesonide Dr	Budesonide	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Unifine Pentips	Pen Needle, Diabetic	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Vancomycin Hcl	Vancomycin Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Penicillin V Potassium	Penicillin V Potassium	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$131.17 · 2 records	Lilly USA, LLC	Dexcom G6 Transmitter, KISUNLA	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error